Across TCGA pan-cancer cohorts, HSPE1P23 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of HSPE1P23’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where HSPE1P23 RNA is repressed in tumor relative to normal tissue. In most cancer types HSPE1P23 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.
LUAD and LUSC are the cancer types where HSPE1P23 tumor–normal differential expression is most reproducible.